Bad data is driving fear of a second wave of Covid-19

The recent spike in Covid-19 “cases” is very different to the original outbreak, says James Ferguson of MacroStrategy Partnership. The government needs to calm down.

Covid-19 cases are on the rise again, particularly amongst the young. The “rule of six” is now nationwide. Localised lockdowns are in place up north. And even martial-law-style 10pm curfews are being considered. So-called “pillar 2” cases from the wider community – where “cases” are a misnomer for “positive” test results – have doubled in the last two weeks from about 2% to roughly 4%. Is this the long-awaited second wave? And once all these infected young northerners visit their grandfathers (ill, elderly men are particularly vulnerable), will it turn into an increase in deaths too? 

This seems to be what our politicians fear – hence their aggressive response. However they are making some major mistakes. One is the policy direction itself – the correct response is not a lockdown of the general population, but shielding of the vulnerable. The other is in misinterpreting the data. “Positives” are not the same as “cases” (the latter require both symptoms and a doctor’s diagnosis).

This leads to a dilemma because, as you can see from the chart on page 23 (which runs to 12 September), although positives have leapt sevenfold from their June-July low, deaths over the same period have fallen by two thirds. 

The epidemiological rule-of-thumb is that the number of (unseen) infections will be roughly ten times the number of diagnosed cases, which in turn will be roughly ten times greater than the number of deaths. Working backwards from deaths, and taking account of the three-week period of illness, we would expect the UK to have about 2,500 diagnosed cases, of which half would be hospitalised (the government currently reports just 972 hospital patients). That would also suggest 25,000 current infections, or disease prevalence (ie, the percentage of the population who has it) of sub-0.04%.

Yet the pillar 2 community-testing scheme is now finding 4% positives. In other words, the test regime seems to be finding 100 times more positives than the combined data on diagnosed cases, hospital admissions and deaths would suggest. That begs the question: how many of these are false positives?

Why false positives really matter

It might surprise you to learn that a positive medical test result does not often – or even usually – mean that an asymptomatic patient has a disease. If the false positive rate (FPR) is the same as the prevalence of the disease, then half of all positives will be false. And the lower the prevalence compared to the FPR, the more inaccurate the results will be. Even doctors don’t tend to grasp the full implications of that.

In 1982, a researcher called David Eddy provided physicians with a diagnostic puzzle. Women age 40, participate in routine screening for breast cancer, with a prevalence of 1%. The mammogram test has a false negative rate of 20% and an FPR of 10%. What is the probability that a woman with a positive test has breast cancer? The correct answer is just 7.5%.

In each batch of 100,000 tests, 800 cases (80% of the 1,000 women who actually have breast cancer) will be picked up. But so too will 9,920 (10% FPR) of the 99,200 healthy women. So the chance of having breast cancer if you test positive is still only 7.46% (800/10,720). However, 95 out of 100 doctors gave answers in the range of 70-80%, ten times higher than the correct answer. 

Not a whole lot has changed since that study. 

To read the whole of this article, subscribe to MoneyWeek magazine

Subscribers can see the whole article in the digital edition available here

Recommended

The US Federal Reserve is about to rein in its money-printing – what does that mean for markets?
US Economy

The US Federal Reserve is about to rein in its money-printing – what does that mean for markets?

America’s central bank is talking surprisingly tough about tightening monetary policy. And it’s not the only one. John Stepek looks at what it all mea…
23 Sep 2021
The uranium price is soaring – here’s the best way to play it now
Energy

The uranium price is soaring – here’s the best way to play it now

Uranium, the key ingredient to nuclear power, has been ignored since the bubble of 2006, but now the uranium price is rising again. Dominic Frisby exp…
22 Sep 2021
I wish I knew what contagion was, but I’m too embarrassed to ask
Too embarrassed to ask

I wish I knew what contagion was, but I’m too embarrassed to ask

Most of us probably know what “contagion” is in a biological sense. But it also crops up in financial markets. Here's what it means.
21 Sep 2021
Why is the UK short of CO2 and what does it mean for you?
UK Economy

Why is the UK short of CO2 and what does it mean for you?

The UK is experiencing a carbon dioxide shortage that could lead to empty shelves in supermarkets. Saloni Sardana explains what’s going on and how it …
21 Sep 2021

Most Popular

The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021
Two shipping funds to buy for steady income
Investment trusts

Two shipping funds to buy for steady income

Returns from owning ships are volatile, but these two investment trusts are trying to make the sector less risky.
7 Sep 2021
How to stop recurring subscriptions becoming a drain on your money
Personal finance

How to stop recurring subscriptions becoming a drain on your money

Tracking and pruning subscriptions isn’t as easy as it sounds. Here's how to take charge.
14 Sep 2021